Universal Advanced Whitening Anti-cavity Fluoride
Sodium Monofluorophosphate
Universal Distribution Center Llc
Human Otc Drug
NDC 52000-112Universal Advanced Whitening Anti-cavity Fluoride also known as Sodium Monofluorophosphate is a human otc drug labeled by 'Universal Distribution Center Llc'. National Drug Code (NDC) number for Universal Advanced Whitening Anti-cavity Fluoride is 52000-112. This drug is available in dosage form of Paste. The names of the active, medicinal ingredients in Universal Advanced Whitening Anti-cavity Fluoride drug includes Sodium Monofluorophosphate - .76 g/100g . The currest status of Universal Advanced Whitening Anti-cavity Fluoride drug is Active.
Drug Information:
| Drug NDC: | 52000-112 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Universal Advanced Whitening Anti-cavity Fluoride |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Sodium Monofluorophosphate |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Universal Distribution Center Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Paste |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | SODIUM MONOFLUOROPHOSPHATE - .76 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | DENTAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 30 May, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 24 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part355 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Universal Distribution Center LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 545626
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | C810JCZ56Q
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 52000-112-01 | 181 g in 1 TUBE (52000-112-01) | 30 May, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose anticavity toothpaste
Product Elements:
Universal advanced whitening anti-cavity fluoride sodium monofluorophosphate calcium carbonate water glycerin silicon dioxide sodium lauryl sulfate sorbitol xanthan gum saccharin sodium sodium benzoate carboxymethylcellulose sodium, unspecified form fd&c blue no. 1 sodium monofluorophosphate fluoride ion
Indications and Usage:
Uses builds increasing protection against painful sensitivity of teeth due to cold, heat, acids, sweets or contact. aids in the prevention of dental cavities.
Warnings:
Warning
When Using:
When using this product if pain\ sensitivity still persists after 4 weeks of use, please visit your dentist.
Dosage and Administration:
Directions adults and children of 2 years and older: brush teeth thoroughly after meals or at least twice a day, or as directed by a dentist. do not swallow. to minimize swallowing, use a pea-sized amount in children under 6 years old. supervise children's brushing until good habits are established. children under 2 years: ask a dentist before use. children under 12 years of age: consult a dentist or doctor
Stop Use:
Stop and ask a dentist if the problem persists or worsens. sensitivity teeth may indicate a serious problem that may need prompt care by a dentist.
Package Label Principal Display Panel:
Principal display panel universal advanced whitening anti-cavity fluoride toothpaste label